Target intelligence / Profile preview

DNA polymerase alpha, DNA polymerase delta, and DNA polymerase epsilon (Pol α (alpha), Pol δ (delta), Pol ε (epsilon))

Target
Pol α (alpha), Pol δ (delta), Pol ε (epsilon)
Molecular classification
Enzyme, DNA polymerase, B-family DNA polymerase
01

Overview

DNA polymerase alpha, delta, and epsilon are three essential B-family enzymes responsible for the faithful replication of nuclear DNA in eukaryotic cells. DNA polymerase alpha initiates DNA replication by extending RNA primers with short stretches of DNA, after which DNA polymerase delta (primarily lagging strand synthesis) and DNA polymerase epsilon (primarily leading strand synthesis) take over to elongate the majority of the genome[3][7][9]. All three enzymes are multi-subunit complexes with distinct catalytic and regulatory subunits necessary for their function and regulation[5][9]. They play critical roles in cell cycle progression, genome maintenance, and various DNA repair pathways[2][3][6]. Mutations in their genes—particularly those affecting proofreading domains of delta and epsilon—are associated with increased risk of cancer and other diseases due to elevated mutagenesis[3][9]. Several anticancer drugs and experimental inhibitors act by targeting their activity, but the essential nature of these enzymes in healthy proliferating tissues creates therapeutic challenges concerning toxicity[9].

Other names
Pol α, Pol δ, Pol εFamily B DNA polymerases
02

Mechanism of action

Inhibition of DNA polymerase activity, leading to impaired DNA replication and cell cycle arrest - Induction of replication stress, DNA damage, or apoptosis in rapidly dividing cells

03

Biological functions

DNA replicationDNA repairCell cycle regulationGenome stability
04

Disease associations

CancerGenetic instability syndromesOther (mutations linked to various hereditary diseases)
05

Safety considerations

Essential enzymes in normal dividing cells—systemic inhibition can cause myelosuppression, gastrointestinal toxicity, and impairment of normal tissue regenerationMutagenesis risk: defective polymerase proofreading increases cancer risk
06

Interacting drugs

Cytarabine

3 more in the full profile.

07

Biomarkers

Mutations in POLE and POLD1 genes (especially proofreading/exonuclease domains)Expression levels of polymerases in tumor versus normal tissue

Beyond the preview

Go deeper on DNA polymerase alpha, DNA polymerase delta, and DNA polymerase epsilon (Pol α (alpha), Pol δ (delta), Pol ε (epsilon)).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on DNA polymerase alpha, DNA polymerase delta, and DNA polymerase epsilon (Pol α (alpha), Pol δ (delta), Pol ε (epsilon)).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call